Tirzepatide and Semaglutide: Beyond Weight Loss and the Headlines

GLP-1 medications have become some of the most talked-about drugs in medicine. You have likely heard names like tirzepatide, semaglutide, Zepbound, Mounjaro, and Ozempic. Most people recognize the celebrity headlines and dramatic before-and-after weight loss photos, but as a primary care physician, I can tell you the conversation happening in medical offices is much broader than that.

This article is not meant to debate whether people should or should not take GLP-1 medications. These medications are already widely used, increasingly studied, and rapidly becoming part of everyday conversations between patients and their physicians. My goal is simply to provide perspective on emerging research and promising areas of study beyond the tabloid headlines.

Originally developed for diabetes, GLP-1 medications are now being studied for a growing list of conditions. While weight loss often gets the attention, many physicians are interested in their effects on overall metabolic and chronic disease health.

Type 2 diabetes: GLP-1 medications can improve blood sugar control while also helping address long-term complications associated with diabetes.

Heart disease: In patients with established cardiovascular disease, certain GLP-1 medications have demonstrated meaningful reductions in heart attack and stroke risk.

Chronic kidney disease: Newer studies suggest GLP-1 medications may help slow disease progression in some patients.

Metabolic liver disease: Previously known as fatty liver disease, this is something I see frequently in primary care. Early studies suggest GLP-1 medications may reduce liver inflammation and potentially help slow fibrosis progression.

Addiction and compulsive behaviors: Ongoing studies are exploring whether GLP-1 medications may reduce certain reward-driven urges, not only around food, but potentially alcohol and other substances as well.

Inflammation and brain health: Researchers are studying possible roles in neurodegenerative conditions such as Alzheimer's and Parkinson's disease. These findings are still early, but they highlight how much we are continuing to learn about these medications.

As a primary care physician with extensive experience prescribing and managing GLP-1 medications, I also believe it is important to approach them carefully. They are not appropriate for everyone. These medications can have significant side effects, require close follow up, and still need more long-term studies regarding safety and use in certain populations.

GLP-1 medications are not magic, and they are not a replacement for healthy lifestyle habits. However, for the right patient, they may be one useful tool within a much larger picture of improving long-term health.

These are complex conversations that require time to carefully discuss potential benefits, risks, side effects, and whether treatment truly fits a patient’s overall health goals. If you are interested in learning more, I encourage you to schedule a dedicated appointment with your primary care physician.